Posted by AGORACOM-JC
at 9:16 AM on Thursday, August 13th, 2020
Updated Earnings Guidance for Q3 2020 and full year 2020:
Management continues to expect significant revenue growth
Q3 2020 updated EPS> $0.07
Full year 2020 updated EPS > $0.11.
MONTREAL, Aug. 13, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to provide today, further to its Q2 2020 financial press release dated July 29th, 2020, updated earnings per share (“EPS”) guidance for Q3 2020, and the full year 2020.
PyroGenesis now expects EPS for Q3 2020 to be in excess of $0.07. On July 29th, 2020, the Company had given prior guidance of $0.06 for the same period. Furthermore, the Company now expects an EPS for the full year 2020 to be conservatively in excess of $0.11.
“We understand the market’s interest in our providing guidance, so we are progressing cautiously and conservatively as we are committed to meet or exceed market expectations,” said P. Peter Pascali, CEO and President of PyroGenesis. “Our confidence, and increased visibility, in our Q3 2020 results has resulted in this update, and we will continue to provide such updates as needed. The Company continues to exceed internal expectations in the execution of all its projects and business lines with little to no impact from the summer holiday period nor the ongoing pandemic.”
Updated Earnings Guidance for Q3 2020 and full year 2020:
Management continues to expect significant revenue growth
Q3 2020 updated EPS> $0.07
Full year 2020 updated EPS > $0.11.
About PyroGenesis Canada Inc. PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.
Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.
SOURCE PyroGenesis Canada Inc.
For further information please contact: Rodayna Kafal, Vice President Investors Relations and Strategic Business Development Phone: (514) 937-0002, E-mail: [email protected] RELATED LINK: https://www.pyrogenesis.com/
Posted by AGORACOM-JC
at 7:09 AM on Thursday, August 13th, 2020
Announced the signing of a channel reseller partnership with Kentucky-based bdG Sports LLC (“bdG”) a leading representation, event management and public relations firm operating within the global sports marketing industry.
bdG Sports is one of the largest providers of college basketball content in the United States, managing multiple NCAA Division I tournaments across North America, including destination tournaments in Southwest Florida, Las Vegas, Canada, and The Bahamas
The firm manages two professional golf tournaments on the Korn Ferry Tour in the Caribbean, and has an extensive background with both the LPGA and PGA TOUR
The firm also boasts relationships with such brands as Nike, ESPN, Gatorade, and MGM Resorts International, among others.
VANCOUVER, BC, Aug. 13, 2020 – Loop Insights Inc. (MTRX:TSXV) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive automated marketing, contact tracing, and contactless solutions to the brick and mortar space, announces the signing of a channel reseller partnership with Kentucky-based bdG Sports LLC (“bdG”) a leading representation, event management and public relations firm operating within the global sports marketing industry.
LOOP CONTACT TRACING SOLUTION PROVIDES BDG SPORTING EVENTS WITH AN OPPORTUNITY TO COMMENCE AND PROVIDE ECONOMIC RECOVERY FOR CLIENTS
bdG Sports is one of the largest providers of college basketball content in the United States, managing multiple NCAA Division I tournaments across North America, including destination tournaments in Southwest Florida, Las Vegas, Canada, and The Bahamas. The firm manages two professional golf tournaments on the Korn Ferry Tour in the Caribbean, and has an extensive background with both the LPGA and PGA TOUR. The firm boasts relationships with such brands as Nike, ESPN, Gatorade, and MGM Resorts International, among others. As a result of COVID-19, these staple events and many other bdG events have been disrupted, with no plans for commencement without a solution for the safety of fans, athletes, and staff.
President and CEO of bdG Sports, Brooks Downing, said: “Many within our extensive network of business are desperately searching for innovative solutions that will allow them the opportunity to support a safe environment for fans, staff and athletes, but also optimize their revenue streams that warrant the restart of operations. Loop effectively solves both of these problems with its leading contact-tracing solution which will provide the confidence needed as teams make decisions to restart their schedules. And while this tool will allow fans to return to events, Loop’s contactless, artificial intelligence marketing solutions will provide personalized promotions and targeted engagement, leading to higher conversions and transaction revenue at all events. This level of personalized omni-channel marketing is incredibly valuable for our clients’ resumption plans.”
BDG PROVIDES DIRECT ACCESS TO ITS LIVE GLOBAL SPORTING EVENTS AND TO ITS LARGE NETWORK OF CLIENTS WITHIN NBA, NHL, NCAA AND PGA
In addition to implementing Loop’s contact tracing product into its current and future events, bdG Sports also plays host to major global sports events and will be implementing Loop’s solutions to reinvent the live fan engagement experience, consisting of real-time personalized fan engagement.
Additionally, bdG will represent Loop as a reseller to its current and future clients and enables direct access to the bdG Sports client base, which the Company anticipates will accelerate its growth opportunities in the sports industry.
Loop CEO, Rob Anson, stated: “This is a major opportunity for Loop as live event operators are looking for two things that we can immediately solve. First, they are desperately looking to safely re-open facilities in efforts to save their respective seasons, and secondly, they are looking for new line revenue opportunities to offset the losses from reduced fan capacity in stadium. This partnership with globally renowned bdG Sports is major third-party validation of our abilities to deliver these solutions. We look forward to leading the way with them toward the safe and profitable resumption of major sporting events.”
Watch Loop CEO, Rob Anson and bdG Sports CEO, Brooks Downing discuss their new partnership https://youtu.be/cL5wfYNO-Qs
About bdG Sports: bdG Sports is a representation, event management, and public relations firm operating on an international platform within the sports marketing industry. bdG manages multiple college basketball and college hockey events in the United States each season with events in Southwest Florida, Las Vegas and The Bahamas. bdG’s golf division manages the season-opening tournaments of the Korn Ferry Tour each January in The Bahamas, hosts premium Pro-Ams throughout the year and launched the Unbridled Tour mini-tour series in 2020. For more information, visit www.bdglobalsports.com or follow on @bdGlobalSports on Twitter, Facebook or Instagram.
About Loop Insights: Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.
Forward-Looking Statements/Information:
This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year.
1 in 5 Americans will develop skin cancer by the age of 70.
More than 2 people die of skin cancer in the U.S. every hour.
Clearly the world needs a much better early skin cancer screening technology.
MedX Health Corp. (TSXV: MDX) is a leading medical device and software company focused on the early detection of skin cancer. MedX has approvals in 35 countries and distribution agreements in place for its key skin cancer diagnostic products – SIAscope and DermSecure™ telemedicine platform.
Following on from MedX’s regulatory approval and distribution agreement in Brazil (read here), the Company recently announced an exciting exclusive distribution agreement to launch SIAscopy on DermSecure™ in Mexico with EMC LABS, S.A.P.I. DE C.V., operating as MedX Mexico. MedX Mexico plans to launch an aggressive ease-of-access skin scanning/assessment program throughout Mexico, using MedX’s SIAscopy on DermSecure™ Telemedicine platform. MedX Mexico will cover all the upfront costs for application for regulatory approval in Mexico, all marketing costs, and will utilize their large-scale distribution network in Mexico.
MedX Mexico’s, President and CEO, Carlos Vizcaino, states:
“There is a significant opportunity for MedX’s rapid skin assessment technology in Mexico, as skin cancer is a very common type of cancer in Mexico……MedX’s SIAscopy on DermSecure™ Telemedicine platform and advanced SIAscopy imaging technology is a perfect solution to assist dermatologists and physicians in the diagnosis process for early detection of melanoma.”
Masterplan
MedX Health’s masterplan is to continue to rollout distribution agreements with partners globally. So far Brazil and now Mexico are underway. MedX’s revolutionary skin cancer detection device is approved in the USA, Canada, Brazil, Australia, New Zealand, the European Union, Turkey, and many other places. In total MedX’s device has achieved regulatory approval in 35 countries. This means we can expect further distribution agreements in the future to many of the above countries. The potential for future revenues is enormous.
MedX’s business model is similar to Software as a Service (SaaS) companies. The revenue model uses front-end hardware sales coupled with recurring “platform” revenue based on a minimum number of screens per device (360/year at $10/image).
2019 revenues were only small at C$860,248, and 1st quarter 2020 C$95,544, as the Company was impacted by COVID-19 and had yet to ramp up distribution as is now occurring in 2020. For a guide on where revenues are headed the next two years the Beacon Securities report is most useful.
The report’s analysts says MedX has strong visibility on initial orders from the MedX Brazilian distribution partner, that could result in $8 million of hardware sales over the next 2 years and a run-rate of $14 million of high margin, recurring platform revenue by the end of FY21. Given that MedX currently trades on a market cap of C$24 million, the C$14 million, if achieved, would mean MedX would trade on a 2022 market cap/sales ratio of only 1.7. Beacon Securities rates MedX Health a ‘buy’ with a Price Target of C$0.45. Given the stock currently trades at C$0.135, the C$0.45 price target represents a very significant upside of 233% or a 3.3 fold gain.
Closing remarks
It is very clear to me that the market is yet to wake up to the potential very large boost in revenues that MedX is working to achieve, now with distribution agreements in both Brazil and Mexico.
Detecting skin cancer is an enormous global need and MedX is working hard to fill this need. MedX has the right device and approvals in 35 countries. All that is needed now is further distribution agreements and revenue to flow. The opportunity for investors to get in early on such a great company with a very bright future still exists. I would not recommend waiting too long as the cheap valuation is unlikely to last long, especially as further new deals are announced.
Posted by AGORACOM-JC
at 5:25 PM on Wednesday, August 12th, 2020
(TSXV: MTRX)
WHY LOOP INSIGHTS?
What if you could receive the same personalization and experience you get from online shopping, but in brick and mortar stores? Loop Insights is doing just that.
Brick and mortar retail isn’t going anywhere, but it does need to adapt to offer better in-store customer experiences. Loop Insights solves a significant problem for traditional retailers – big and small – who are losing customers to e-commerce retail.
All e-commerce sites have easy access to company-wide connectivity, real-time insights, and personalized marketing. What Loop is doing is creating those same tools for physical retail, whether it is a restaurant, hotel, casino, store, or stadium.
Loop’s proprietary internet of things (IoT) device, Fobi, makes it all happen. It can be installed in minutes using an API or hardware solution, making Loop’s services ultimately scalable no matter what infrastructure is currently set up in the store.
NORTH AMERICA’S BIGGEST MOBILE COMPANIES BELIEVE
SEEING IS BELIEVING
Now that you have an understanding of the magnitude of the problem and the disruptive power of LOOP, you need to see it for yourself. Watch this short but powerful videos demonstrating how LOOP is being applied across different verticals to solve brick and mortar retail problems.
Posted by AGORACOM-JC
at 9:10 AM on Wednesday, August 12th, 2020
Announced that it has secured rights to sell and distribute South Korean manufacturer PCL, Inc.’s (“PCL”) COV05 COVID19 Rapid Antigen Detection Kits
These test kits are suitable for point of care tests. No extra equipment is needed. They are easy to use with over 97% accuracy, and results are available in 5 to 10 minutes
Antigen Rapid Diagnosis Kit developed by PCL is a method of fluorescently measuring the presence of a COVID-19 infection
TORONTO, Aug. 12, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured rights to sell and distribute South Korean manufacturer PCL, Inc.’s (“PCL”) COV05 COVID19 Rapid Antigen Detection Kits. These test kits are suitable for point of care tests. No extra equipment is needed. They are easy to use with over 97% accuracy, and results are available in 5 to 10 minutes.
The Antigen Rapid Diagnosis Kit developed by PCL is a method of fluorescently measuring the presence of a COVID-19 infection. It is an in-vitro diagnostic medicaldevice to detect the SARS-CoV-2 antigen from a person’s oropharyngeal and nasopharyngeal secretions if the specimen contains antigens to SARS-CoV-2, a colored line appears in the T line area.
“According to the manufacturer, PCL, this test can detect antigens of COVID-19 from a swab in the nose or throat and provide results in 10 minutes with over 97% accuracy,” said Marshall Gunter, CEO of Datametrex. “These almost-instant kits can be easily used at home. With the rise of cases in the United States and throughout the world, we at Datametrex believes it is critical to test and protect.”
PCL states that the clinical sensitivity (confirmed the actual positive of the approved person) is 100% and the clinical specificity (confirmed the actual negative of the negative person) is 97.78%. Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.
The following certifications have been awarded to these PCL Antigen Test Kits: CE Certificate, Korea FDA, FIND Listed, UNGM Supplier. Countries includes the EU, 2 countries in the Middle East- Qatar and UAE, India, Russia, 3 countries in Latin America- Guatemala, Ecuador, and Colombia.
The PCL Antigen Detection kit has the CE Certificate meaning that the manufacturer and products have met EU declaration of standards for health, safety, and environmental protection, allowing this product to be sold within the 22 countries in the European Economic Area.
Worldwide, currently there have been over 19.7M people who have been tested positive for COVID-19 but the actual case count is believed to be higher, as a significant number of asymptomatic people may not have been tested. Even more worrying is that most families have had to wait more than 72 hours for their test results to come back from both public and private labs increasing the possibility of spreading the virus.
Rapid Diagnosis Kit is easy when there are no symptoms even after COVID-19 infection, or when ‘positive’ and ‘negative’ are not evident in tests such as RT-PCR. When an infection occurs, an antigen against COVID-19 is formed in the body after some time, so it is a post-test that is essential as a preventive measure.
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time. Health Canada must approve these COVID-19 test kits before they can be used in Canada. The Company plans to sell these kits in all countries where the kits have been approved for sale.
About Datametrex
Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact: Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
The Antigen Rapid Diagnosis Kit developed by PCL is a method of fluorescently measuring the presence of a COVID-19 infection. It is an in-vitro diagnostic medicaldevice to detect the SARS-CoV-2 antigen from a person’s oropharyngeal and nasopharyngeal secretions if the specimen contains antigens to SARS-CoV-2, a colored line appears in the T line area.
“According to the manufacturer, PCL, this test can detect antigens of COVID-19 from a swab in the nose or throat and provide results in 10 minutes with over 97% accuracy,” said Marshall Gunter, CEO of Datametrex. “These almost-instant kits can be easily used at home. With the rise of cases in the United States and throughout the world, we at Datametrex believes it is critical to test and protect.”
PCL states that the clinical sensitivity (confirmed the actual positive of the approved person) is 100% and the clinical specificity (confirmed the actual negative of the negative person) is 97.78%. Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.
The following certifications have been awarded to these PCL Antigen Test Kits: CE Certificate, Korea FDA, FIND Listed, UNGM Supplier. Countries includes the EU, 2 countries in the Middle East- Qatar and UAE, India, Russia, 3 countries in Latin America- Guatemala, Ecuador, and Colombia.
The PCL Antigen Detection kit has the CE Certificate meaning that the manufacturer and products have met EU declaration of standards for health, safety, and environmental protection, allowing this product to be sold within the 22 countries in the European Economic Area.
Worldwide, currently there have been over 19.7M people who have been tested positive for COVID-19 but the actual case count is believed to be higher, as a significant number of asymptomatic people may not have been tested. Even more worrying is that most families have had to wait more than 72 hours for their test results to come back from both public and private labs increasing the possibility of spreading the virus.
Rapid Diagnosis Kit is easy when there are no symptoms even after COVID-19 infection, or when ‘positive’ and ‘negative’ are not evident in tests such as RT-PCR. When an infection occurs, an antigen against COVID-19 is formed in the body after some time, so it is a post-test that is essential as a preventive measure.
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time. Health Canada must approve these COVID-19 test kits before they can be used in Canada. The Company plans to sell these kits in all countries where the kits have been approved for sale.
About Datametrex
Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact: Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM
at 10:31 AM on Tuesday, August 11th, 2020
SPONSOR: Lomiko Metals is focused on the exploration and development of minerals for the new green economy such as lithium and graphite. Lomiko has an option for 100% of the high-grade La Loutre graphite Property, Lac Des Iles Graphite Property and the 100% owned Quatre Milles Graphite Property. Lomiko is uniquely poised to supply the growing EV battery market. Click Here For More Information
One of the most overlooked and undersold benefits of converting to electric vehicles is the impact that they have on their owners’ wallets.
A myth has emerged about their running costs that have seen people overlook the long-term financial benefits that EVs afford.
This is a welcome addition to their environmental credentials amidst rising fuel prices and increasing levies against internal combustion engine (ICE) vehicles in city centres.
Today’s article seeks to bust this myth and show you why switching to EV could save you money, and save the planet.
EV’s: Pricing up the difference
As of the writing of this article, we concede that the average EV costs more than the Internal Combustion Engine (ICE).
Although we are witnessing a rapid change in this area.
The latest generation of electric vehicles are coming to market at the same cost as their petrol or diesel counterparts.
Furthermore, we can compare the two best sellers in each category, the ICE Ford Fiesta, and the EV Nissan Leaf.
We see that the €4,000 ($4,490/£3,400) difference in purchase price can be overcome within just three years for the average driver.
Talking tax
Vehicle tax rates are calculated based on the car’s carbon dioxide (CO2) emissions per kilometre.
Tax breaks for zero-emissions vehicles, alongside governmental incentives such as grants, have been a key factor in the growing number of EVs on the road.
A recent study by the International Council for Clean Transport found that EV owners could save as much as 27% each year compared to driving diesel equivalents.
Their analysis, which compared the same make and model of vehicles across EV, petrol, and diesel found that drivers in Norway would save 27% in running costs by going electric.
The average driver in the study could save between 11-15%.
The UK offered the lowest savings in running costs at 5% due to the recent cuts in grants for EVs.
The average ICE in Europe emits 112g/km of CO2, equating to €153 (£140) per year in tax.
In addition, the average EV offers around €70 ($78/£60) per year in servicing savings.
Predominantly there are fewer moving parts in electric vehicles so they create less friction and therefore less wear.
The lower average running temperatures also help to reduce wear and offer greater efficiency.
Charging the change
Finally, the most obvious saving comes from the fuel source that is used to power each vehicle.
Based on current electricity prices, a car costs 15c per kWh to charge ($0.17c/£0.13), meaning that a mid-range EV driving around 9,000 miles per year would cost €274 or 2.7c per mile in running costs.
This is vastly cheaper than the petrol equivalent of the same vehicle, which would cost around €965 ($1,084/£825) per year to refuel, costing 9.1c per mile.
In fact, according to the UK Government’s Ultra Low Campaign, the average ICE costs 12c per mile to run.
The difference is even starker when you consider that the most efficient ICEs covert just 17-21% of their fuel into power, while EVs deliver around 59-62%.
Furthermore, when teamed with localised renewable energy sources, electric vehicles can save you even more money.
And of course, help you push towards a neutral carbon footprint for energy consumption.
Low wear, fewer tears
An oft-overlooked benefit of electric vehicles over their ICE counterparts is that their motors are highly simplified.
They have fewer moving parts and they do not require regular oil changes to ensure that they run efficiently.
The upside of which is that wear is greatly reduced, as are maintenance costs – meaning fewer trips to the mechanic and a potential saving of around €70 (£60) per year.
In addition, with great gains being made in battery and motor efficiency, technical issues can be overcome through wireless software updates sent directly to your electric car.
A great example is Mercedes’ innovation of acclimatising batteries to their ideal temperature in advance of you starting go charge.
This is not a technical issue per se, but one that elongates the life and increases the efficiency of the batteries.
You can find out more about this in Robert Llewellyn’s test drive of the Mercedes-Benz EQC.
Preparing for the future
While many are choosing not to consider the future of their ICE vehicle, it is clear that their days are numbered, and that they will not continue to hold their value in the years ahead.
Paris has led a number of global cities in legislating a ban on diesel vehicles from 2024.
This has taken the next step of banning the sale of all ICEs from 2030 as the French capital aims to become carbon-neutral by 2050.
We expect this trend to increase in the coming years as lawmakers push to meet climate targets.
They also want to cut the number of deaths associated with carbon emissions from traffic
This is estimated to account for nearly 500,000 early deaths per year in the EU alone.
Can you afford to miss out on the benefits of electric vehicles? In the face of an accelerating climate crisis, the world can’t.
Posted by AGORACOM
at 8:07 AM on Tuesday, August 11th, 2020
VANCOUVER, British Columbia, Aug. 11, 2020 (GLOBE NEWSWIRE) — Candente Copper Corp. (TSX:DNT, BVL:DNT) (“Candente Copper” or the “Company”) advises that Mr. Luis Miguel Inchaustegui Zevallos has resigned as Advisor and Director of our Peruvian subsidiary, Cañariaco Copper Perú S.A. (”Cañariaco”) and has been named Minister of Energy and Mines of Peru.
We thank Mr. Inchaustegui for all of his excellent advice and wish him all the best in his new endeavours.
On another matter the Company also advises that the Board of Directors has adopted a new shareholder rights plan (“Rights Plan”), which is designed to encourage the fair treatment of the Company’s Shareholders in connection with any potential take‑over bid for the Company. The Rights Plan is not intended to deter or prevent take‑over bids and is similar to plans adopted recently by several other Canadian public companies and approved by their Shareholders.
Background and Purpose of the Rights Plan
The Rights Plan will:
encourage the fair treatment of shareholders of the Company in connection with any Offer to Acquire the outstanding Voting Shares;
ensure, to the extent possible, that the shareholders of the Company and the Board of Directors have adequate time to consider and evaluate any unsolicited Offer to Acquire the outstanding Voting Shares;
ensure, to the extent possible, that the Board of Directors has adequate time to identify, develop and negotiate value-enhancing alternatives, as appropriate, to any unsolicited Offer to Acquire the outstanding Voting Shares; and
generally assist the Board of Directors to enhance shareholder value.
Take‑over bid contests for corporate control provide a singular opportunity for Shareholders to obtain a one‑time gain. After the acquisition of effective control, the opportunity for this one‑time gain normally does not re‑occur. As with most public companies, it is possible for a person to secure control of the Company through the ownership of much less than 50% of the Company’s shares. Without a shareholder rights plan, a bidder could acquire effective control of the Company over a relatively short period of time, through open market and private purchases and using various techniques permitted under Canadian securities legislation, all without making a bid available to all Shareholders. This acquisition of control would probably be an effective deterrent to other potential offerors. The person acquiring control might also be able to consolidate and increase its control, over a period of time, without the price for control ever being tested through an open market auction. Shareholder rights plans are designed to prevent this occurrence by forcing all acquisitions of control into a public offer mode.
A public offer will not necessarily achieve all of the objectives of ensuring the maximum value to Shareholders. The Rights Plan is intended to provide the Board with sufficient time to pursue alternatives and to provide Shareholders with sufficient time to properly assess any take‑over bid.
The Company is not proposing the Rights Plan in response to or in anticipation of any acquisition or take‑over bid. The Rights Plan is not intended to prevent a take‑over of the Company, to secure continuance of current management or the directors in office, or to deter fair offers for the Company’s shares. The Rights Plan does not inhibit or prevent any Shareholder from using the proxy mechanism set out in the BCBCA to promote a change in the management or direction of the Company. The Rights Plan may, however, increase the price to be paid by a potential offeror to obtain control of the Company and may discourage certain transactions.
The Rights Plan does not affect in any way the Company’s financial condition. The initial issuance of the Rights will not dilute the Company’s shares and will not affect reported earnings or cash flow per share until the Rights separate from the underlying common shares and become exercisable. The adoption of the Rights Plan will not lessen or affect the duty of the Company’s directors to act honestly, in good faith, and in the Company’s best interests. The Rights Plan is designed to provide the directors with the means to negotiate with an offeror and with sufficient time to seek out and identify alternative transactions on behalf of the Shareholders.
The Rights Plan is subject to Toronto Stock Exchange and Shareholder approval at the upcoming Annual General Meeting on September 17th, 2020. If the Shareholders do not approve the Rights Plan, it will terminate or not become effective, as applicable. The Rights Plan will also expire if the Rights are redeemed by the Company. A copy of the Rights Plan Agreement can be requested for review to [email protected].Once the Rights Plan has been approved, it will be filed on SEDAR at www.sedar.com and posted on the Company’s website at www.candentecopper.com.
About Candente Copper Candente Copper is a mineral exploration company engaged in acquisition, exploration, and development of mineral properties. The Company is currently focused on its 100% owned Cañariaco project, which includes the Feasibility stage Cañariaco Norte deposit as well as the Cañariaco Sur deposit and Quebrada Verde prospect, located within the western Cordillera of the Peruvian Andes in the Department of Lambayeque in Northern Peru.
At Cañariaco Norte, 7.5 billion pounds of copper have been delineated in a Measured and Indicated* resource of 752.4 million tonnes grading 0.49% copper equivalent** and an Inferred Resource of 157.7 million tonnes at 0.44% copper equivalent has also been delineated.
Fifteen drill holes have confirmed that Cañariaco Sur hosts a porphyry-copper deposit, however the average grade and full dimensions of the deposit are as yet unknown. Quebrada Verde also hosts a geochemical and geophysical target where porphyry style copper mineralization is exposed in creek beds.
Candente Copper also holds other porphyry copper-gold exploration projects in Peru.
Joanne C. Freeze, P.Geo., CEO, is the Qualified Person as defined by National Instrument 43-101 for the projects discussed above. She has reviewed and approved the contents of this release.
*The ‘Measured and Indicated Resource listed above consists of Measured Resources of 338.1Mt at 0.48% Cu , 0.08 g/t Au, and 2.0/t Ag (0.52% Cu Eq.), plus Indicated Resources of 414.3Mt at 0.43% Cu, 0.06 g/t Au, and 1.8 g/t Ag (o.46% Cu Eq.). All resources quoted in this release are based on a 0.30% copper cut-off grade and 229 drill holes completed to the end of 2008.
**Copper equivalent grade including gold and silver, metal recoveries (copper 90%, gold 55%; silver 50%) and smelter returns (copper 96.5%: gold 93%; silver 90%) applied. Copper grade equivalent calculation: Cu Eq% =(Cu % + ((Au grade x Au price x Au recovery x Au smelter return%)+(Ag grade x Ag price x Ag recovery x Ag smelter return%))/(22.0462 x Cu price x 31.0135 g/t x Cu recovery x Cu smelter return%). The metal prices used are: copper US$2.50/lb, gold US$1,035/oz and silver US$17.25/oz.
On behalf of the Board of Candente Copper Corp.
“Joanne C. Freeze” P.Geo. President, CEO and Director ___________________________________ For further information please contact:
Posted by AGORACOM-JC
at 8:02 PM on Monday, August 10th, 2020
AGORACOM prides itself on becoming the discovery platform of emerging disruptive companies …. and we’ve discovered another one today in Vegaste Technologies, an e-commerce driven platform that is delivering all things plant-based to customers across Canada right now.
Vegaste has already started with both plant-based food meals directly to homes, thanks to partnerships right across the country – but isn’t stopping there as it adds hundreds of products to the platform. More than just lip service, Vegaste is already on a $US 3,000,000 run rate and that will probably accelerate in the coming months as marketing and additional products kick in.
Vegaste Founder, Sean Dollinger, is no stranger to AGORACOM followers as he was the Co-Founder behind wildly successful Namaste Technologies before it fell on hard times experienced by the cannabis industry. In addition to bringing back his immense e-commerce capabilities, he’s also implemented some valuable lessons learned at Namaste when it comes to corporate governance and share structure.
One of those lessons was appointing Julia Frank as CEO and giving her the team necessary to focus on doing the best job possible. Julia’s experience combines both start-up and big corporation structures thanks to being part of start-up teams within both BMW and Daimler in Germany.
Vegaste is hot off the listing press, so if you ever wanted to get a jump on your fellow investor it doesn’t get much fresher than this ….. unless you’re ordering a plant based meal off their platform at www.PlantX.com
If you believe in the paradigm shifting nature of plant based foods, be sure to watch and share this great interview with Vegaste CEO Julia Frank CEO & Founder Sean Dollinger.
Posted by AGORACOM-JC
at 3:35 PM on Monday, August 10th, 2020
Announced two webinars taking place on August 11th and 20th
Viewers can log on to RBMG’s live webinar at 4:30PM ET on Aug 11 (1:30PM PT)
Viewers can log on to SmallCap Power’s live webinar at 11:00AM ET on Aug 20th (8AM PT)
VANCOUVER, BC, Aug. 10, 2020 – Loop Insights Inc. (TSXV: MTRX) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated contact tracing to the brick and mortar space, announced two webinars taking place on August 11th and 20th through two esteemed investing firm platforms, SmallCap Power and RB Milestone Group (“RBMG”).
HOW TO REGISTER
Loop CEO Rob Anson will be providing an investor update on Loop’s current operations, its upcoming milestones, and how the Company is leveraging its technology for contactless, automated contact tracing to assist brick and mortar businesses reopen their doors in an expedited and safe manner during the pandemic
Viewers can log on to RBMG‘s live webinar at 4:30PM ET on Aug 11 (1:30PM PT).
A STRATEGIC MOVE TO INCREASE THE COMPANY‘S VISIBILITY EXPONENTIALLY
The Company will leverage the two firms’ large investor audiences to widen its visibility and diversify its investment portfolio. SmallCap Power is known to highlight young, innovative companies that have significant growth potential and offers an addressable investor audience of 3 million. RBMG offers Loop a proprietary database comprised of over 10,000 institutional investors, HNWs, UHNWs, family offices, brokers and research analysts throughout the US, setting the stage for Loop’s in-progress listing on the OTCQB® American Venture Market.
CEO Rob Anson explained: “There’s no greater time to become acquainted with Loop’s story and fully understand the scope of this investing opportunity. The company is gaining huge market traction. In July we traded more stocks than we have in this past year while being on the public market; and on July 17th, we saw a 100% increase in stock price. We are catching fire, and we want this to be known among the global investor community.”
About SmallCapPower: SmallCapPower is the industry’s leading and most trusted source for small-cap stock coverage, research, and analysis. Our investment philosophy is predicated on discovering smaller, underfollowed, and under researched public companies, which have significant growth potential.
About RBMG: Our US advisory practice delivers investor relations programs tailor-made for emerging companies who are private and publicly traded on the NYSE, NASDAQ, OTC, TSX, TSXV, CSE, ASX and AIM. It helps companies refine their communications strategies, weigh data, and advise clients on how to penetrate new markets.
About Loop Insights: Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.
Forward-Looking Statements/Information:
This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM
at 11:47 AM on Monday, August 10th, 2020
SPONSOR: Mota Ventures Corp is an established natural health products company focused in the CBD and psychedelic medicine sectors. Through their powerful eCommerce business, Mota is a leading direct-to-consumer provider of a wide range of natural health products throughout the United States and Europe. Click Here for More Info
Psychedelic science is making a comeback.
Scientific publications, therapeutic breakthroughs and cultural endorsements suggest that the historical reputation of psychedelics — such as lysergic acid diethylamide (LSD), mescaline (from the peyote cactus) and psilocybin (mushrooms) — as dangerous or inherently risky have unfairly overshadowed a more optimistic interpretation. Recent publications, like Michael Pollan’s How to Change your Mind, showcase the creative and potentially therapeutic benefits that psychedelics have to offer — for mental health challenges like depression and addiction, in palliative care settings and for personal development.
I am a medical historian, exploring why we now think that psychedelics may have a valuable role to play in human psychology, and why over 50 years ago, during the heyday of psychedelic research, we rejected that hypothesis. What has changed? What did we miss before? Is this merely a flashback?
Osmond studied mescaline from the peyote cactus, synthesized by German scientists in the 1930s, and LSD, a laboratory-produced substance created by Albert Hofmann at Sandoz in Switzerland. During the 1950s and into the 1960s, more than 1,000 scientific articles appeared as researchers around the world interrogated the potential of these psychedelics for healing addictions and trauma.
But, by the end of the 1960s, most legitimate psychedelic research ground to a halt. Some of the research had been deemed unethical, namely mind-control experiments conducted under the auspices of the CIA. Other researchers had been discredited for either unethical or self-aggrandizing use of psychedelics, or both.
View original content to download multimedia: 
